|
Originally published In Press as doi:10.1074/jbc.M208535200 on September 23, 2002
J. Biol. Chem., Vol. 277, Issue 50, 48094-48098, December 13, 2002
Cell Condition-dependent Regulation of ERK5 by
cAMP*
Gray W.
Pearson and
Melanie H.
Cobb§
From the Department of Pharmacology, University of Texas
Southwestern Medical Center, Dallas, Texas 75390-9041
ERK5 activity is increased by agents known to
activate receptor tyrosine kinases, G-protein coupled receptors, and
stress response pathways. We now find a role for cAMP in the regulation of ERK5. ERK5 is activated by forskolin, isoproterenol, and epinephrine in NIH3T3 cells and C2C12 myoblasts. ERK1/2 are also activated by cAMP
in NIH3T3 cells, but not in C2C12 myoblasts, demonstrating differential
regulation of ERK5 and ERK1/2 by cAMP. We examined the effect of cell
context on activation of ERK5 and discovered ERK5 activity is
inhibited, rather than activated, by cAMP in confluent, serum-deprived
NIH3T3 cells and C2C12 myoblasts. Our results suggest that regulation
of MAP kinase pathways by cAMP is not only dictated by cell type, but
also by cell context.
*
This work was supported by National Institutes of Health
Grant DK34128 and Welch Foundation Grant I1243.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by an NIGMS, National Institutes of Health, Predoctoral
Training Grant in the pharmacological sciences. This work was done in
partial fulfillment of the requirements for the Ph.D. degree.
§
To whom correspondence should be addressed: Dept. of Pharmacology,
University of Texas Southwestern Medical Center, 5323 Harry Hines
Blvd., Dallas, TX 75390-9041. Tel.: 214-648-3627; Fax: 214-648-3811; E-mail: mcobb@mednet.swmed.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. W. Pearson, S. Earnest, and M. H. Cobb
Cyclic AMP Selectively Uncouples Mitogen-Activated Protein Kinase Cascades from Activating Signals
Mol. Cell. Biol.,
April 15, 2006;
26(8):
3039 - 3047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Hii, D. S. Anson, M. Costabile, V. Mukaro, K. Dunning, and A. Ferrante
Characterization of the MEK5-ERK5 Module in Human Neutrophils and Its Relationship to ERK1/ERK2 in the Chemotactic Response
J. Biol. Chem.,
November 26, 2004;
279(48):
49825 - 49834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-e Xu, S. Stippec, L. Lenertz, B.-H. Lee, W. Zhang, Y.-K. Lee, and M. H. Cobb
WNK1 Activates ERK5 by an MEKK2/3-dependent Mechanism
J. Biol. Chem.,
February 27, 2004;
279(9):
7826 - 7831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Alto, S. H. Soderling, N. Hoshi, L. K. Langeberg, R. Fayos, P. A. Jennings, and J. D. Scott
Bioinformatic design of A-kinase anchoring protein-in silico: A potent and selective peptide antagonist of type II protein kinase A anchoring
PNAS,
April 15, 2003;
100(8):
4445 - 4450.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|